AI could spot hidden lung danger in scleroderma patients
NCT ID NCT07236970
First seen Nov 19, 2025 · Last updated Jun 20, 2026 · Updated 35 times
Summary
This study is testing whether artificial intelligence (AI) can better detect a serious lung condition called pulmonary arterial hypertension (PAH) in people with scleroderma. Researchers will compare AI algorithms to traditional screening methods in 350 patients across multiple hospitals in Spain. The goal is to see if AI can catch PAH earlier and more accurately, which could lead to better outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, Andalusia, 18007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, Madrid, 28034, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Catalonia, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
artificial intelligence algorithms
What this could lead to
If successful, this could lead to a more accurate, non-invasive screening method for early detection of pulmonary hypertension in scleroderma patients, potentially improving survival and quality of life.
What could go wrong
This is an observational study using existing data and AI models, not a treatment trial. The algorithms may not perform better than current methods, and results may not apply to all patient groups.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.